Synthetic Approaches to the New Drugs Approved during 2023
Scott P. France, Erick A. Lindsey, Emma L. McInturff, Simon Berritt, Jacob C. DeForest, Andrew C. Flick, Sarah J. Fink, Tony Gibson, Kaitlyn Gray, Aran K. Hubbell, Amber M. Johnson, Yiyang Liu, Subham Mahapatra, Rebecca B. Watson, Zhiyao Zhou
Abstract
This review is the next installment of an annual series that discusses the synthetic routes to access 28 small molecule drugs that were approved worldwide in 2023. A brief description of each drug's mechanism of action, the history of its discovery and development, and the synthetic approaches published in primary or patent literature that were most likely used for clinical studies or development are included. Synthetic chemistry, used to convert complex intermediates to active compounds or build a new drug from basic building block chemicals, is critical to delivery of new drugs and treatments for disease to patients.